Coming Off Ozempic Slowly Could Prevent Weight Gain, Study Shows

May 11, 2024, 10:01 PM UTC

Patients could wean themselves off blockbuster drugs such as Ozempic or Wegovy without piling the pounds back on, according to a scientific study.

Data presented at the European Congress on Obesity in Venice, Italy on Sunday provides some of the first evidence that it could be possible to stop taking Novo Nordisk’s Ozempic or Wegovy and not regain any weight that has been lost — as long as a healthy lifestyle is maintained.

When drugs like Ozempic and Eli Lilly’s Zepbound were first launched, they were pitched as long-term medicines, with research indicating that patients regain large amounts ...

Learn more about Bloomberg Law or Log In to keep reading:

Learn About Bloomberg Law

AI-powered legal analytics, workflow tools and premium legal & business news.

Already a subscriber?

Log in to keep reading or access research tools.